Vaccine strategies: Optimising outcomes

dc.contributor.authorHardt, Karin
dc.contributor.authorBonanni, Paolo
dc.contributor.authorKing, Susan
dc.contributor.authorSantos, Jose Ignacio
dc.contributor.authorEl-Hodhod, Mostafa
dc.contributor.authorZimet, Gregory D.
dc.contributor.authorPreiss, Scott
dc.contributor.departmentDepartment of Pediatrics, School of Medicineen_US
dc.date.accessioned2017-08-30T15:31:04Z
dc.date.available2017-08-30T15:31:04Z
dc.date.issued2016-12
dc.description.abstractSuccessful immunisation programmes generally result from high vaccine effectiveness and adequate uptake of vaccines. In the development of new vaccination strategies, the structure and strength of the local healthcare system is a key consideration. In high income countries, existing infrastructures are usually used, while in less developed countries, the capacity for introducing new vaccines may need to be strengthened, particularly for vaccines administered beyond early childhood, such as the measles or human papillomavirus (HPV) vaccine. Reliable immunisation service funding is another important factor and low income countries often need external supplementary sources of finance. Many regions also obtain support in generating an evidence base for vaccination via initiatives created by organisations including World Health Organization (WHO), the Pan American Health Organization (PAHO), the Agence de Médecine Préventive and the Sabin Vaccine Institute. Strong monitoring and surveillance mechanisms are also required. An example is the efficient and low-cost approaches for measuring the impact of the hepatitis B control initiative and evaluating achievement of goals that have been established in the WHO Western Pacific region. A review of implementation strategies reveals differing degrees of success. For example, in the Americas, PAHO advanced a measles-mumps-rubella vaccine strategy, targeting different population groups in mass, catch-up and follow-up vaccination campaigns. This has had much success but coverage data from some parts of the region suggest that children are still not receiving all appropriate vaccines, highlighting problems with local service infrastructures. Stark differences in coverage levels are also observed among high income countries, as is the case with HPV vaccine implementation in the USA versus the UK and Australia, reflecting differences in delivery settings. Experience and research have shown which vaccine strategies work well and the factors that encourage success, which often include strong support from government and healthcare organisations, as well as tailored, culturally-appropriate local approaches to optimise outcomes.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationHardt, K., Bonanni, P., King, S., Santos, J. I., El-Hodhod, M., Zimet, G. D., & Preiss, S. (2016). Vaccine strategies: Optimising outcomes. Vaccine, 34(52), 6691-6699. https://doi.org/10.1016/j.vaccine.2016.10.078en_US
dc.identifier.urihttps://hdl.handle.net/1805/13970
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.vaccine.2016.10.078en_US
dc.relation.journalVaccineen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.sourcePublisheren_US
dc.subjectvaccinationen_US
dc.subjectstrategyen_US
dc.subjectnational immunization programen_US
dc.titleVaccine strategies: Optimising outcomesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hardt_2016_vaccine.pdf
Size:
362.7 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: